Economic evidence to inform substance use disorder (SUD), hepatitis C (HCV), and HIV treatment decisions is vitally important in today?s rapidly evolving healthcare system. The overall aim of CHERISH (Center for Health Economics of TReatment Interventions for Substance Use Disorder, HCV, and HIV) is to develop and disseminate economic evidence that informs substance use treatment policy and HCV and HIV care of substance users, and to increase the impact of this research by addressing the needs of integrated healthcare system providers and payers. No single institution has the critical mass of researchers to accomplish this task alone. We have, therefore, assembled a team of outstanding researchers with diverse expertise and perspectives across several world-class institutions, many of whom have extensive histories of previous successful collaborations with one another. The proposed Center will include 5 Cores: a Methodology Core located at Weill Cornell Medical College, an HCV and HIV Core located at Boston Medical Center, a Dissemination and Policy Core located at the University of Pennsylvania Leonard Davis Institute for Health Economics (LDI), and a Pilot Grant and Training Core and an Administrative Core both located at Weill Cornell Medical College. The Center will also have an external Policy Advisory Board (supported by the Policy and Dissemination Core) and an external Center Advisory Board (supported by the Administrative Core). The Administrative Core?s specific aims are 1) to provide scientific and programmatic leadership that ensures efficient and successful coordination and integration of activities across Center Cores, and 2) to use technology to facilitate productive communication across locations and disciplines and self-evaluation of progress towards meeting Core and Center objectives. The Administrative Core will convene monthly cross- Core leadership meetings and maintain a schedule of frequent face-to-face interactions throughout the year that will rotate among Core locations. The Administrative Core will be innovative in the way that it uses web- based technologies to support formal and informal research interactions that cross locations and disciplines. These strategies and technologies will include a website/portal, a listserv and wiki, and hosting and managing telecommunications, file-sharing and file storage platforms. The Administrative Core will use a structured management process, supported by an administrative tracking system, to monitor and evaluate the Center?s progress towards meeting its objectives. These activities will support a highly productive and interactive environment in which the Center will promote synergy among researchers and institutions that will enhance existing research projects and develop of a new cohort of investigators with the skills needed to conduct SUD economic research that will have an impact on SUD, HCV, and HIV treatment policy.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
New York
United States
Zip Code
McCollister, Kathryn E; Leff, Jared A; Yang, Xuan et al. (2018) Cost of pharmacotherapy for opioid use disorders following inpatient detoxification. Am J Manag Care 24:526-531
Kapadia, Shashi N; Johnston, Carrie D; Marks, Kristen M et al. (2018) Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity. J Public Health Manag Pract :
Bachhuber, Marcus A; Saloner, Brendan; LaRochelle, Marc et al. (2018) Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs. Pain Med 19:1952-1960
McCollister, Kathryn; Baumer, Pamela; Davis, Monica et al. (2018) Economic Evaluation of the Juvenile Drug Court/Reclaiming Futures (JDC/RF) Model. J Behav Health Serv Res 45:321-339
Freiman, J Morgan; Jacobson, Karen R; Muyindike, Winnie R et al. (2018) Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr 77:405-412
Kapadia, Shashi N; Jeng, Philip J; Schackman, Bruce R et al. (2018) State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals. Clin Infect Dis 66:1618-1620
Friedmann, Peter D; Wilson, Donna; Nunes, Edward V et al. (2018) Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder? J Subst Abuse Treat 85:61-65
Kapadia, Shashi N; Wu, Chunyuan; Mayer, Kenneth H et al. (2018) No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PLoS One 13:e0206577
McCollister, Kathryn E; Yang, Xuan; Murphy, Sean M et al. (2018) Criminal justice measures for economic data harmonization in substance use disorder research. Health Justice 6:17
Chen, Donna T; Ko, Tomohiro M; Allen, Ashleigh A et al. (2018) Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision. J Empir Res Hum Res Ethics 13:160-172

Showing the most recent 10 out of 93 publications